SLE Peripheral Blood B Cell, T Cell and Myeloid Cell Transcriptomes Display Unique Profiles and Each Subset Contributes to the Interferon Signature

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Becker, Amy M ^a,b   Dao, Kathryn H ^b   Han, Bobby Kwanghoon ^b   Kornu, Roger ^b   Lakhanpal, Shuchi ^b   Mobley, Angela B ^a   Li, Quan Zhen ^a   Lian, Yun ^a   Wu, Tianfu ^b   Reimold, Andreas M ^b   Olsen, Nancy J ^b   Karp, David R ^b   Chowdhury, Fatema Z ^a   Farrar, J David ^a   Satterthwaite, Anne B ^a,b   Mohan, Chandra ^a,b   Lipsky, Peter E ^c   Wakeland, Edward K ^a   Davis, Laurie S ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD63 ANTIGEN; CYTOKINE; DNA; INTERFERON; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PREDNISONE; RNA; SIALOADHESIN; TRANSCRIPTOME;

ADULT; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL ISOLATION; CELL SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSOL; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; MALE; MOLECULAR SENSOR; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TRANSCRIPTOMICS; UPREGULATION;

ADULT; B-LYMPHOCYTES; DNA; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INTERFERONS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; MYELOID CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; RNA; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; TRANSCRIPTOME; UP-REGULATION; YOUNG ADULT;

EID: 84879467018     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067003     Document Type: Article

References (77)

1. Crow MK, (2008) Collaboration, genetic associations, and lupus erythematosus. N Engl J Med 358: 956-961.
2. Petri M, (1995) Clinical features of systemic lupus erythematosus. Curr Opin Rheumatol 7: 395-401.
3. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, et al. (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349: 1526-1533.
4. Heinlen LD, Ritterhouse LL, McClain MT, Keith MP, Neas BR, et al. (2010) Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides. J Mol Med (Berl) 88: 719-727.
5. Mathian A, Gallegos M, Pascual V, Banchereau J, Koutouzov S, (2011) Interferon-alpha induces unabated production of short-lived plasma cells in pre-autoimmune lupus-prone (NZBxNZW)F1 mice but not in BALB/c mice. Eur J Immunol 41: 863-872.
6. Ytterberg SR, Schnitzer TJ, (1982) Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum 25: 401-406.
7. Bengtsson AA, Sturfelt G, Truedsson L, Blomberg J, Alm G, et al. (2000) Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 9: 664-671.
8. Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, et al. (1979) Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 301: 5-8.
9. Kirou KA, Lee C, George S, Louca K, Peterson MG, et al. (2005) Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 52: 1491-1503.
10. Liu Z, Bethunaickan R, Huang W, Ramanujam M, Madaio MP, et al. (2011) IFN-alpha confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice. J Immunol 187: 1506-1513.
11. Kiefer K, Oropallo MA, Cancro MP, Marshak-Rothstein A, (2012) Role of type I interferons in the activation of autoreactive B cells. Immunol Cell Biol 90: 498-504.
12. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, et al. (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100: 2610-2615.
13. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, et al. (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197: 711-723.
14. Ye S, Pang H, Gu YY, Hua J, Chen XG, et al. (2003) Protein interaction for an interferon-inducible systemic lupus associated gene, IFIT1. Rheumatology (Oxford) 42: 1155-1163.
15. Han GM, Chen SL, Shen N, Ye S, Bao CD, et al. (2003) Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray. Genes Immun 4: 177-186.
16. Li QZ, Zhou J, Lian Y, Zhang B, Branch VK, et al. (2010) Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes. Clin Exp Immunol 159: 281-291.
17. Han BK, White AM, Dao KH, Karp DR, Wakeland EK, et al. (2005) Increased prevalence of activated CD70+CD4+ T cells in the periphery of patients with systemic lupus erythematosus. Lupus 14: 598-606.
18. Consortium M, Shi L, Reid LH, Jones WD, Shippy R, et al. (2006) The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24: 1151-1161.
19. Tomayko MM, Anderson SM, Brayton CE, Sadanand S, Steinel NC, et al. (2008) Systematic comparison of gene expression between murine memory and naive B cells demonstrates that memory B cells have unique signaling capabilities. J Immunol 181: 27-38.
20. Yao Y, Richman L, Higgs BW, Morehouse CA, de los Reyes M, et al. (2009) Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus. Arthritis Rheum 60: 1785-1796.
21. Kirou KA, Lee C, George S, Louca K, Papagiannis IG, et al. (2004) Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum 50: 3958-3967.
22. Li S, Wang L, Berman M, Kong YY, Dorf ME, (2011) Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity 35: 426-440.
23. Satoh T, Kato H, Kumagai Y, Yoneyama M, Sato S, et al. (2010) LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci U S A 107: 1512-1517.
24. Furukawa H, Oka S, Matsui T, Hashimoto A, Arinuma Y, et al. (2013) Genome, epigenome and transcriptome analyses of a pair of monozygotic twins discordant for systemic lupus erythematosus. Hum Immunol 74: 170-175.
25. Arce E, Jackson DG, Gill MA, Bennett LB, Banchereau J, et al. (2001) Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J Immunol 167: 2361-2369.
26. Dorner T, Lipsky PE, (2004) Correlation of circulating CD27high plasma cells and disease activity in systemic lupus erythematosus. Lupus 13: 283-289.
27. Rivero SJ, Diaz-Jouanen E, Alarcon-Segovia D, (1978) Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. Arthritis Rheum 21: 295-305.
28. Winfield JB, Winchester RJ, Kunkel HG, (1975) Association of cold-reactive antilymphocyte antibodies with lymphopenia in systemic lupus erythematosus. Arthritis Rheum 18: 587-594.
29. Isenberg DA, Patterson KG, Todd-Pokropek A, Snaith ML, Goldstone AH, (1982) Haematological aspects of systemic lupus erythematosus: a reappraisal using automated methods. Acta Haematol 67: 242-248.
30. Robinson T, Kariuki SN, Franek BS, Kumabe M, Kumar AA, et al. (2011) Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-alpha and serologic autoimmunity in lupus patients. J Immunol 187: 1298-1303.
31. Crampton SP, Deane JA, Feigenbaum L, Bolland S, (2012) Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity. J Immunol 188: 1451-1459.
32. Ronnblom L, (2011) The type I interferon system in the etiopathogenesis of autoimmune diseases. Ups J Med Sci 116: 227-237.
33. Guerra SG, Vyse TJ, Cunninghame Graham DS, (2012) The genetics of lupus: a functional perspective. Arthritis Res Ther 14: 211.
34. Biswas PS, Gupta S, Stirzaker RA, Kumar V, Jessberger R, et al. (2012) Dual regulation of IRF4 function in T and B cells is required for the coordination of T-B cell interactions and the prevention of autoimmunity. J Exp Med 209: 581-596.
35. Shin DM, Lee CH, Morse HC, 3rd (2011) IRF8 governs expression of genes involved in innate and adaptive immunity in human and mouse germinal center B cells. PLoS One 6: e27384.
36. Cavlar T, Ablasser A, Hornung V, (2012) Induction of type I IFNs by intracellular DNA-sensing pathways. Immunol Cell Biol 90: 474-482.
37. Choubey D, Panchanathan R, Duan X, Liu H, (2011) Emerging roles for the interferon-inducible p200-family proteins in sex bias in systemic lupus erythematosus. J Interferon Cytokine Res 31: 893-906.
38. Schattgen SA, Fitzgerald KA, (2011) The PYHIN protein family as mediators of host defenses. Immunol Rev 243: 109-118.
39. Lugar PL, Love C, Grammer AC, Dave SS, Lipsky PE, (2012) Molecular characterization of circulating plasma cells in patients with active systemic lupus erythematosus. PLoS One 7: e44362.
40. Mellor-Pita S, Citores MJ, Castejon R, Yebra-Bango M, Tutor-Ureta P, et al. (2009) Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus. Cytometry B Clin Cytom 76: 261-270.
41. Jones BM, Liu T, Wong RW, (1999) Reduced in vitro production of interferon-gamma, interleukin-4 and interleukin-12 and increased production of interleukin-6, interleukin-10 and tumour necrosis factor-alpha in systemic lupus erythematosus. Weak correlations of cytokine production with disease activity. Autoimmunity 31: 117-124.
42. Ettinger R, Kuchen S, Lipsky PE, (2008) Interleukin 21 as a target of intervention in autoimmune disease. Ann Rheum Dis 67Suppl 3: iii83-86.
43. Odegard JM, Marks BR, DiPlacido LD, Poholek AC, Kono DH, et al. (2008) ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J Exp Med 205: 2873-2886.
44. Nicholas MW, Dooley MA, Hogan SL, Anolik J, Looney J, et al. (2008) A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE. Clin Immunol 126: 189-201.
45. Efremov DG, Gobessi S, Longo PG, (2007) Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells. Autoimmun Rev 7: 102-108.
46. Wu T, Qin X, Kurepa Z, Kumar KR, Liu K, et al. (2007) Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus. J Clin Invest 117: 2186-2196.
47. Jacobi AM, Reiter K, Mackay M, Aranow C, Hiepe F, et al. (2008) Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis Rheum 58: 1762-1773.
48. Odendahl M, Jacobi A, Hansen A, Feist E, Hiepe F, et al. (2000) Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 165: 5970-5979.
49. Jenks SA, Sanz I, (2009) Altered B cell receptor signaling in human systemic lupus erythematosus. Autoimmun Rev 8: 209-213.
50. Mietzner B, Tsuiji M, Scheid J, Velinzon K, Tiller T, et al. (2008) Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc Natl Acad Sci U S A 105: 9727-9732.
51. Shapiro-Shelef M, Calame K, (2005) Regulation of plasma-cell development. Nat Rev Immunol 5: 230-242.
52. Vinuesa CG, Cook MC, (2001) The molecular basis of lymphoid architecture and B cell responses: implications for immunodeficiency and immunopathology. Curr Mol Med 1: 689-725.
53. Su GH, Chen HM, Muthusamy N, Garrett-Sinha LA, Baunoch D, et al. (1997) Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B. EMBO J 16: 7118-7129.
54. Hystad ME, Myklebust JH, Bo TH, Sivertsen EA, Rian E, et al. (2007) Characterization of early stages of human B cell development by gene expression profiling. J Immunol 179: 3662-3671.
55. de Goer de Herve MG, Durali D, Dembele B, Giuliani M, Tran TA, et al. (2011) Interferon-alpha triggers B cell effector 1 (Be1) commitment. PLoS One 6: e19366.
56. Liu N, Ohnishi N, Ni L, Akira S, Bacon KB, (2003) CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells. Nat Immunol 4: 687-693.
57. Wang D, John SA, Clements JL, Percy DH, Barton KP, et al. (2005) Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease. Int Immunol 17: 1179-1191.
58. Bell SG, Vallee BL, (2009) The metallothionein/thionein system: an oxidoreductive metabolic zinc link. Chembiochem 10: 55-62.
59. Yin X, Knecht DA, Lynes MA, (2005) Metallothionein mediates leukocyte chemotaxis. BMC Immunol 6: 21.
60. O'Neil J, Look AT, (2007) Mechanisms of transcription factor deregulation in lymphoid cell transformation. Oncogene 26: 6838-6849.
61. Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, et al. (2013) Sodium chloride drives autoimmune disease by the induction of pathogenic T17 cells. Nature.
62. Wu C, Yosef N, Thalhamer T, Zhu C, Xiao S, et al. (2013) Induction of pathogenic T17 cells by inducible salt-sensing kinase SGK1. Nature.
63. Harada T, Kyttaris V, Li Y, Juang YT, Wang Y, et al. (2007) Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration. Autoimmunity 40: 1-8.
64. Li Y, Harada T, Juang YT, Kyttaris VC, Wang Y, et al. (2007) Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus. J Immunol 178: 1938-1947.
65. Kyttaris VC, Wang Y, Juang YT, Weinstein A, Tsokos GC, (2007) Increased levels of NF-ATc2 differentially regulate CD154 and IL-2 genes in T cells from patients with systemic lupus erythematosus. J Immunol 178: 1960-1966.
66. Kyttaris VC, Wang Y, Juang YT, Weinstein A, Tsokos GC, (2006) CAMP response element modulator a expression in patients with systemic lupus erythematosus. Lupus 15: 840-844.
67. Chowdhury FZ, Ramos HJ, Davis LS, Forman J, Farrar JD, (2011) IL-12 selectively programs effector pathways that are stably expressed in human CD8+ effector memory T cells in vivo. Blood 118: 3890-3900.
68. Katsiari CG, Tsokos GC, (2006) Transcriptional repression of interleukin-2 in human systemic lupus erythematosus. Autoimmun Rev 5: 118-121.
69. Scatizzi JC, Mavers M, Hutcheson J, Young B, Shi B, et al. (2009) The CDK domain of p21 is a suppressor of IL-1beta-mediated inflammation in activated macrophages. Eur J Immunol 39: 820-825.
70. Kim K, Sung YK, Kang CP, Choi CB, Kang C, et al. (2009) A regulatory SNP at position-899 in CDKN1A is associated with systemic lupus erythematosus and lupus nephritis. Genes Immun 10: 482-486.
71. Silva FP, Morolli B, Storlazzi CT, Zagaria A, Impera L, et al. (2008) ETV6 mutations and loss in AML-M0. Leukemia 22: 1639-1643.
72. Carella C, Potter M, Bonten J, Rehg JE, Neale G, et al. (2006) The ETS factor TEL2 is a hematopoietic oncoprotein. Blood 107: 1124-1132.
73. Lee J, Kuchen S, Fischer R, Chang S, Lipsky PE, (2009) Identification and characterization of a human CD5+ pre-naive B cell population. J Immunol 182: 4116-4126.
74. Biesen R, Demir C, Barkhudarova F, Grun JR, Steinbrich-Zollner M, et al. (2008) Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus. Arthritis Rheum 58: 1136-1145.
75. Ohshima S, Kuchen S, Seemayer CA, Kyburz D, Hirt A, et al. (2003) Galectin 3 and its binding protein in rheumatoid arthritis. Arthritis Rheum 48: 2788-2795.
76. Henderson NC, Sethi T, (2009) The regulation of inflammation by galectin-3. Immunol Rev 230: 160-171.
77. Lau KS, Dennis JW, (2008) N-Glycans in cancer progression. Glycobiology 18: 750-760.